학술논문
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens
Document Type
Article
Author
Podzamczer, D.; Imaz, A.; Navarro-Alcaraz, A.; Lopez-Lirola, A.; Knobel, H.; Masiá, M.; Fanciulli, C.; Hernández, C.; Lagarde, M.; Gutierrez, A.; Curran, A.; Morano, L.; Montero-Alonso, M.; Troya, J.; Rigo, R.; Casadellà, M.; Ardila, F.; Parera, M.; Bernal, E.; Echeverria, P.; Estrada, V.; Hidalgo-Tenorio, C.; Macias, J.; Prieto, P.; Portilla, J.; Valencia, E.; Vivancos, M.J.; Rivero, A.
Source
In: Journal of Antimicrobial Chemotherapy . (Journal of Antimicrobial Chemotherapy, 1 November 2023, 78(11):2696-2701)
Subject
Language
English
ISSN
14602091
03057453
03057453